Therapies for treating pulmonary diseases
AssigneeSmithKline Beecham Corporation
InventorsRichard Nieman, Anthony S Rebuck, Theodore J Torphy
Life of this patent
Estimating the term…
Abstract
This invention relates to treating pulmonary diseases such as chronic obstructive pulmonary disease or asthma by administering a phosphodiesterase 4 inhibitor in combination with beta adrenergic bronchodilator.
Claims4
A pharmaceutical composition for use in treating a pulmonary disease and formulated for delivery as an inhaled powder and comprising cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate] or a pharmaceutically acceptable salt, polymorph or hydrate thereof and a long-acting beta2 adrenergic bronchodilator which is formoterol, albuterol, metaproterenol or terbutaline;
- each in an amount effective for treating said pulmonary disease;
- and a pharmaceutically acceptable excipient.
A pharmaceutical composition for use in treating a pulmonary disease and formulated for delivery as an aerosol and comprising cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate] or a pharmaceutically acceptable salt, polymorph or hydrate thereof and a long-acting beta2 adrenergic bronchodilator which is formoterol, albuterol, metaproterenol or terbutaline;
- each in an amount effective for treating said pulmonary disease;
- and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.